ProfileGDS5678 / 1433277_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 20% 19% 19% 20% 19% 20% 19% 19% 19% 19% 19% 19% 19% 19% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4968120
GSM967853U87-EV human glioblastoma xenograft - Control 22.4613219
GSM967854U87-EV human glioblastoma xenograft - Control 32.4638119
GSM967855U87-EV human glioblastoma xenograft - Control 42.4177920
GSM967856U87-EV human glioblastoma xenograft - Control 52.4049819
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5283520
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4920119
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4377219
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4254919
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4487519
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4455219
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4320419
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4548319
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4599419